Eleszto Genetika provides microbial synthetic biology and protein expression services, including pathway design, strain construction, high-throughput screening, and stirred-tank fermentation/DSP process development.
Eleszto Genetika (EG) provides services for microbial synthetic biology, including pathway design, DNA construct building, multiplexed strain engineering, and high-throughput screening. The company also offers analytics and sequencing (including NGS), enzyme engineering, and process development such as stirred tank fermentation and downstream processing (DSP) process development in yeast. In addition to yeast-based engineering, EG provides protein expression and protein improvement services across multiple microbial platforms, including E. coli, yeast, Pichia, Bacillus, and filamentous fungi, supporting the genetic modification work used to create microbial strains for production of high-value target molecules or proteins through novel metabolic pathways.
These capabilities matter to partners looking to develop and scale microbial production programs: EG describes contract research running microbial synthetic biology or protein expression projects, strain and process supply for large-scale fermentation (including non-exclusive licensing), and small-scale production/purification for different compounds up to 200 L. By combining design, construction, screening, and bioprocess development in a single workflow, the company positions itself to help partners identify and create metabolic pathways and production processes for target molecules or proteins.